Free Trial

Arcus Biosciences (RCUS) News Today

Arcus Biosciences logo
$9.06 +0.05 (+0.50%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$8.97 -0.09 (-1.05%)
As of 05/27/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RCUS Latest News

Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Millennium Management LLC
Millennium Management LLC boosted its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 277.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 924,369 shares of th
Arcus Biosciences, Inc. stock logo
Woodline Partners LP Purchases 45,497 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)
Woodline Partners LP lifted its stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 1.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,523,937 shares of the company's stock after buying an additional 45,497
Arcus Biosciences, Inc. stock logo
Suvretta Capital Management LLC Has $8.58 Million Stock Position in Arcus Biosciences, Inc. (NYSE:RCUS)
Suvretta Capital Management LLC reduced its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 13.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 576,156 shares of the company's stock af
Arcus Biosciences, Inc. stock logo
Point72 Asset Management L.P. Sells 440,794 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)
Point72 Asset Management L.P. reduced its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 18.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,996,279 shares of the company's stock afte
Arcus Biosciences, Inc. stock logo
Ameriprise Financial Inc. Boosts Stake in Arcus Biosciences, Inc. (NYSE:RCUS)
Ameriprise Financial Inc. raised its position in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 17.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,547,591 shares of the company's stock after buyin
Arcus Biosciences, Inc. stock logo
Parkman Healthcare Partners LLC Acquires 248,035 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)
Parkman Healthcare Partners LLC grew its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 24.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,273,789 shares of the company's stock after buying an additional 248,035 shar
Arcus Biosciences, Inc. stock logo
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Arcus Biosciences, Inc. (NYSE:RCUS)
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 140.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 76,646 shares of the
Arcus Biosciences, Inc. stock logo
Jacobs Levy Equity Management Inc. Invests $6.93 Million in Arcus Biosciences, Inc. (NYSE:RCUS)
Jacobs Levy Equity Management Inc. purchased a new position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 465,304 shar
Arcus Biosciences, Inc. stock logo
Cubist Systematic Strategies LLC Grows Position in Arcus Biosciences, Inc. (NYSE:RCUS)
Cubist Systematic Strategies LLC raised its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 220.3% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 225,167 shares of the company's stock after purchasing an additional 154,874 shar
Arcus Biosciences, Inc. stock logo
Q2 EPS Estimates for Arcus Biosciences Cut by HC Wainwright
Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) - Investment analysts at HC Wainwright cut their Q2 2025 earnings per share (EPS) estimates for Arcus Biosciences in a research note issued on Wednesday, May 7th. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings pe
Arcus Biosciences, Inc. stock logo
Q2 Earnings Forecast for Arcus Biosciences Issued By Wedbush
Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) - Research analysts at Wedbush cut their Q2 2025 earnings estimates for shares of Arcus Biosciences in a note issued to investors on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the company will earn ($1.11) per share for t
Arcus Biosciences, Inc. stock logo
Raymond James Financial Inc. Makes New Investment in Arcus Biosciences, Inc. (NYSE:RCUS)
Raymond James Financial Inc. acquired a new position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 35,662 shares
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Position Increased by Algert Global LLC
Algert Global LLC lifted its holdings in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 59.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 180,122 shares of the company's stock after buying an additional 67,275 shares during the qu
Arcus Biosciences, Inc. stock logo
Arcus Biosciences (NYSE:RCUS) Shares Gap Down Following Weak Earnings
Arcus Biosciences (NYSE:RCUS) Shares Gap Down After Earnings Miss
Arcus Biosciences, Inc. stock logo
Wells Fargo & Company Lowers Arcus Biosciences (NYSE:RCUS) Price Target to $26.00
Wells Fargo & Company reduced their price objective on Arcus Biosciences from $29.00 to $26.00 and set an "overweight" rating for the company in a research note on Wednesday.
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Purchased by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP grew its holdings in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 11.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,702,302 shares of the company's stock after buying an addition
Arcus Biosciences, Inc. stock logo
Braidwell LP Buys Shares of 802,100 Arcus Biosciences, Inc. (NYSE:RCUS)
Braidwell LP purchased a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 802,100 shares of the company's stock, valued at approximately $11
Arcus Biosciences, Inc. stock logo
Schonfeld Strategic Advisors LLC Sells 538,841 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)
Schonfeld Strategic Advisors LLC reduced its position in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 80.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 134,997 shares of the company's stock afte
Arcus Biosciences, Inc. stock logo
Renaissance Technologies LLC Lowers Stock Holdings in Arcus Biosciences, Inc. (NYSE:RCUS)
Renaissance Technologies LLC cut its holdings in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 89.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,500 shares of the company's stock after selling 1
Q1 2025 Arcus Biosciences Inc Earnings Call
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Average Recommendation of "Buy" from Brokerages
Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) has earned an average recommendation of "Buy" from the ten analysts that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and
Arcus Biosciences, Inc. stock logo
Boxer Capital Management LLC Makes New $23.86 Million Investment in Arcus Biosciences, Inc. (NYSE:RCUS)
Boxer Capital Management LLC acquired a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 1,602,200 shares of the company's stock, valued at approximately $23
Arcus Biosciences, Inc. stock logo
PDT Partners LLC Acquires 38,116 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)
PDT Partners LLC lifted its holdings in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 43.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 125,752 shares of the company's stock after acquiring an add
Arcus Biosciences, Inc. stock logo
Arcus Biosciences (RCUS) Expected to Announce Quarterly Earnings on Tuesday
Arcus Biosciences (NYSE:RCUS) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-arcus-biosciences-inc-stock/)
Arcus Biosciences, Inc. stock logo
Adage Capital Partners GP L.L.C. Buys New Stake in Arcus Biosciences, Inc. (NYSE:RCUS)
Adage Capital Partners GP L.L.C. bought a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 443,000 shares of the company's stock, valued at approximately $6,596,000. Adage Capital Partners
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Invesco Ltd.
Invesco Ltd. grew its stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 203,987 shares of the company's stock after buying an addit
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Sold by Decheng Capital LLC
Decheng Capital LLC reduced its stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 808,789 shares of the company's stock after selling 61,
Arcus Biosciences, Inc. stock logo
Diadema Partners LP Acquires New Shares in Arcus Biosciences, Inc. (NYSE:RCUS)
Diadema Partners LP bought a new position in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 165,965 shares of the company's sto
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Sold by Alliancebernstein L.P.
Alliancebernstein L.P. trimmed its stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 94.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,510 shares of the company's stock after selling 1,228,444 sh
Arcus Biosciences, Inc. stock logo
Gilead Sciences Inc. Invests $447.61 Million in Arcus Biosciences, Inc. (NYSE:RCUS)
Gilead Sciences Inc. purchased a new stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 30,061,124 shares of the company's stock,
Arcus Biosciences, Inc. stock logo
Arcus Biosciences (NYSE:RCUS) Shares Down 5.5% - Time to Sell?
Arcus Biosciences (NYSE:RCUS) Stock Price Down 5.5% - Time to Sell?
Arcus Biosciences, Inc. stock logo
Norges Bank Buys Shares of 34,044 Arcus Biosciences, Inc. (NYSE:RCUS)
Norges Bank purchased a new position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 34,044 shares of the company's stock, valued at approximately $507,0
Arcus Biosciences, Inc. stock logo
ExodusPoint Capital Management LP Acquires New Shares in Arcus Biosciences, Inc. (NYSE:RCUS)
ExodusPoint Capital Management LP acquired a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 60,193 shares of the company's stock, valued at approximately
Arcus Biosciences, Inc. stock logo
Vanguard Group Inc. Sells 79,539 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)
Vanguard Group Inc. trimmed its position in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,389,216 shares of the company's stock after
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Recommendation of "Buy" from Brokerages
Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report) has been given a consensus recommendation of "Buy" by the ten research firms that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation, eight have issued a buy recommendation a
Arcus Biosciences, Inc. stock logo
Arcus Biosciences (NYSE:RCUS) Reaches New 12-Month Low - What's Next?
Arcus Biosciences (NYSE:RCUS) Reaches New 12-Month Low - Time to Sell?
Arcus Biosciences, Inc. stock logo
Raymond James Financial Inc. Takes Position in Arcus Biosciences, Inc. (NYSE:RCUS)
Raymond James Financial Inc. acquired a new stake in Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 35,662 shares of the comp
Arcus Biosciences, Inc. stock logo
Arcus Biosciences, Inc. (NYSE:RCUS) Shares Bought by Trexquant Investment LP
Trexquant Investment LP boosted its stake in shares of Arcus Biosciences, Inc. (NYSE:RCUS - Free Report) by 241.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 300,548 shares of the company's stock after purch
Get Arcus Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter.

RCUS Media Mentions By Week

RCUS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RCUS
News Sentiment

0.87

1.03

Average
Medical
News Sentiment

RCUS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RCUS Articles
This Week

3

6

RCUS Articles
Average Week

Get Arcus Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:RCUS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners